Published in Behav Brain Res on October 01, 1997
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) (2003) 1.49
Reward guides vision when it's your thing: trait reward-seeking in reward-mediated visual priming. PLoS One (2010) 1.48
Aversive stimuli differentially modulate real-time dopamine transmission dynamics within the nucleus accumbens core and shell. J Neurosci (2012) 1.28
Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing. J Psychopharmacol (2011) 0.85
Dopamine D1 receptor involvement in latent inhibition and overshadowing. Int J Neuropsychopharmacol (2011) 0.85
Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males. Neuropsychopharmacology (2010) 0.84
Enhanced latent inhibition in dopamine receptor-deficient mice is sex-specific for the D1 but not D2 receptor subtype: implications for antipsychotic drug action. Int J Neuropsychopharmacol (2008) 0.82
Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia. Psychopharmacology (Berl) (2003) 0.80
When to hold that thought: an experimental study showing reduced inhibition of pre-trained associations in schizophrenia. PLoS One (2012) 0.78
Resting lateralized activity predicts the cortical response and appraisal of emotions: an fNIRS study. Soc Cogn Affect Neurosci (2015) 0.78
Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone. Psychopharmacology (Berl) (2009) 0.78
Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion. Psychopharmacology (Berl) (2003) 0.77
Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning. Psychopharmacology (Berl) (2002) 0.76
Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli. Int J Neuropsychopharmacol (2011) 0.76
A pre-clinical study showing how dopaminergic drugs administered during pre-exposure can impair or facilitate latent inhibition. Psychopharmacology (Berl) (2004) 0.75
Quantifying the biodiversity value of tropical primary, secondary, and plantation forests. Proc Natl Acad Sci U S A (2007) 3.41
Determining priorities for change in primary care: the value of practice-based needs assessment. Br J Gen Pract (1997) 2.18
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol (2005) 2.07
Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun (1988) 2.04
Characterization of long-term femoral-head-penetration rates. Association with and prediction of osteolysis. J Bone Joint Surg Am (2000) 2.02
Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem (1972) 1.96
Single mothers, poverty and depression. Psychol Med (1997) 1.89
The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series. Br J Clin Psychol (2005) 1.59
Contraction of single smooth muscle cells from Bufo marinus stomach. Nature (1971) 1.57
Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol (2007) 1.43
Colony-forming cells and colony-stimulating activity during listeriosis in genetically resistant or susceptible mice. Cell Immunol (1986) 1.43
Uptake of gentamicin by bullfrog saccular hair cells in vitro. J Assoc Res Otolaryngol (2003) 1.40
Latent inhibition: interpretation of amphetamine effects in novel paradigms. Psychopharmacology (Berl) (1995) 1.39
Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats. Psychopharmacology (Berl) (2001) 1.26
Ro RNP associated Y RNAs are highly conserved among mammals. Biochim Biophys Acta (1993) 1.19
The determination of kynurenine in plasma. Clin Chim Acta (1975) 1.18
Home delivery: chemotherapy and pizza? BMJ (2001) 1.09
In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. J Pharmacol Exp Ther (1994) 1.07
A dansylation microassay for some amino acids in brain. Anal Biochem (1975) 1.06
Childhood adversity, parental vulnerability and disorder: examining inter-generational transmission of risk. J Child Psychol Psychiatry (2002) 1.03
Adult attachment style. I: Its relationship to clinical depression. Soc Psychiatry Psychiatr Epidemiol (2002) 1.03
Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine. J Control Release (1999) 1.02
Adult attachment style. II: Its relationship to psychosocial depressive-vulnerability. Soc Psychiatry Psychiatr Epidemiol (2002) 1.02
The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res Brain Res Rev (2000) 0.99
Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology (1990) 0.99
Dealing with daily hassles: smoking and African-American adolescent girls. J Adolesc Health (2001) 0.99
Tryptophan metabolism in the isolated perfused liver of the rat: effects of tryptophan concentration, hydrocortisone and allopurinol on tryptophan pyrrolase activity and kynurenine formation. Br J Pharmacol (1976) 0.98
Evidence for perceptual masking of the discriminative morphine stimulus. Psychopharmacology (Berl) (1989) 0.96
Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience (1993) 0.96
Lifetime stressors and recurrent depression: preliminary findings of the Adult Life Phase Interview (ALPHI). Soc Psychiatry Psychiatr Epidemiol (2000) 0.95
The metabolism of a tryptophan load in rat brain and liver. The influence of hydrocortisone and allopurinol. Biochem Pharmacol (1976) 0.95
Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology (2004) 0.95
The effect of amphetamine on Kamin blocking and overshadowing. Behav Pharmacol (2003) 0.94
The determination of kynurenine by gas-liquid chromatography; evidence for its presence in rat brain [proceedings]. Br J Pharmacol (1977) 0.93
Comparison of in vivo wear between polyethylene liners articulating with ceramic and cobalt-chrome femoral heads. J Bone Joint Surg Br (2000) 0.93
Positive identification of kynurenine in rat and human brain [proceedings]. Biochem Soc Trans (1978) 0.93
Increased extracellular dopamine in the nucleus accumbens of the rat during associative learning of neutral stimuli. Neuroscience (1998) 0.92
Clostridium botulinum in British soil. J Hyg (Lond) (1980) 0.92
Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J Pharmacol Exp Ther (1981) 0.92
The Vulnerable Attachment Style Questionnaire (VASQ): an interview-based measure of attachment styles that predict depressive disorder. Psychol Med (2003) 0.92
RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization. J Pharmacol Exp Ther (1996) 0.92
The determination of 5-hydroxytryptophan and its metabolites in plasma following administration to man. Clin Chim Acta (1976) 0.91
The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav Brain Res (1995) 0.91
Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning. Neuroscience (2000) 0.90
In vivo apparent affinity and efficacy estimates for mu opiates in a rat tail-withdrawal assay. Psychopharmacology (Berl) (1998) 0.90
Behavioral and cognitive interventions in the treatment of pain in children. Pediatr Clin North Am (2000) 0.90
Conditioned appetitive stimulus increases extracellular dopamine in the nucleus accumbens of the rat. Eur J Neurosci (2002) 0.89
Serum colony stimulating activity and colony forming cells in murine brucellosis: relationship to immunopathology. Microb Pathog (1987) 0.89
Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys. Fed Proc (1982) 0.89
Increased dopamine release in vivo in nucleus accumbens and caudate nucleus of the rat during drinking: a microdialysis study. Neuroscience (1992) 0.89
Function of glandular secretions in fragrance collection by male euglossine bees (Apidae: Euglossini). J Chem Ecol (1989) 0.89
Oral contraceptives, depression, and aminoacid metabolism. Lancet (1970) 0.88
Monoamine metabolism in senile dementia of Alzheimer type. J Neurol Sci (1983) 0.88
Letter: Tryptophan plus a pyrrolase inhibitor for depression? Lancet (1975) 0.87
Site-specific inactivation of the photophosphorylation reactions of Anabeana variabilis. Biochim Biophys Acta (1969) 0.87
Dense collagen matrix accelerates osteogenic differentiation and rescues the apoptotic response to MMP inhibition. Bone (2008) 0.87
Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Ann Oncol (2001) 0.87
Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids. Psychopharmacology (Berl) (2000) 0.86
Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. J Pharmacol Exp Ther (1984) 0.86
Chronic postweaning lead exposure and response duration performance. Toxicol Appl Pharmacol (1981) 0.86
Effect of radiographic quality on computer-assisted head penetration measurements. Clin Orthop Relat Res (2001) 0.86
Nonfloral sources of chemicals that attract male euglossine bees (Apidae: Euglossini). J Chem Ecol (1993) 0.86
Determination of kynurenine by a simple gas-liquid chromatographic method applicable to urine, plasma, brain and cerebrospinal fluid. J Chromatogr (1978) 0.85
Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings. Br J Psychiatry (1979) 0.85
Tolerance and cross-tolerance to morphine-like stimulus effects of mu opioids in rats. Psychopharmacology (Berl) (1997) 0.85
Conditionally immortalized, multipotential and multifunctional neural stem cell lines as an approach to clinical transplantation. Cell Transplant (2000) 0.84
Electrochemical activity of o-phthalaldehyde-mercaptoethanol derivatives of amino acids. Application to high-performance liquid chromatographic determination of amino acids in plasma and other biological materials. J Chromatogr (1983) 0.84
Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology (1984) 0.84
The metabolism of a tryptophan load in rat brain and liver: the influence of L-alpha-methyldopa hydrazine (MK-486, Carbidopa). Biochem Soc Trans (1978) 0.84
Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: involvement of the hippocampo-accumbens pathway. Neuropharmacology (1996) 0.83
Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone. Psychopharmacology (Berl) (1986) 0.83
Evidence for dopamine D(1) receptor involvement in the stimulus selection task: overshadowing in the rat. Psychopharmacology (Berl) (2002) 0.83
Continuous glutamate leakage from brain cells is balanced by compensatory high-affinity reuptake transport. Neurosci Lett (1987) 0.82
Effect of amygdaloid kindling on the content and release of amino acids from the amygdaloid complex: in vivo and in vitro studies. J Neurochem (1995) 0.82
In vivo voltammetry--present electrodes and methods. Neuroscience (1988) 0.82
Effect of splenectomy on production of interferon and colony-stimulating factor in Listeria monocytogenes-infected mice. Infect Immun (1984) 0.82
Differential modification of pentobarbital stimulus control by d-amphetamine and ethanol. Pharmacol Biochem Behav (1986) 0.82
Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J Neurochem (1991) 0.82
The functional importance of increased brain tryptophan in the serotonergic response to restraint stress. Neuropharmacology (1981) 0.81
Chemical, modulus and cell attachment studies of reactive calcium phosphate filler-containing fast photo-curing, surface-degrading, polymeric bone adhesives. Acta Biomater (2010) 0.81
Effects of food deprivation and immobilization on tryptophan and other amino acids in rat brain. J Neurochem (1973) 0.81
Stress-induced release of 5-HT in the hippocampus and its dependence on increased tryptophan availability: an in vivo electrochemical study. Brain Res (1983) 0.81
Central I1-imidazoline receptors as targets of centrally acting antihypertensive drugs. Clinical pharmacology of moxonidine and rilmenidine. Ann N Y Acad Sci (1999) 0.81
Dopaminergic mechanisms and cognitive deficit in schizophrenia. A neurobiological model. Psychopharmacology (Berl) (1979) 0.81
Prevalence and correlates of recent vaginal douching among African American adolescent females. J Pediatr Adolesc Gynecol (2011) 0.81
Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist. Behav Brain Res (1996) 0.81
Receptor mechanisms of opioid drug discrimination. Psychopharmacol Ser (1988) 0.81
Effects of naloxone on schedule-controlled behavior in morphine-maintained pigeons. J Pharmacol Exp Ther (1978) 0.81
Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys. Psychopharmacology (Berl) (1981) 0.80
D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors. Neuropsychopharmacology (2013) 0.80
Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. J Pharmacol Exp Ther (1993) 0.80
Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron. Psychopharmacology (Berl) (1994) 0.79
Establishing morphine and U-50,488H as discriminative stimuli in a three-choice assay with pigeons. Exp Clin Psychopharmacol (1998) 0.79
Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia. J Psychopharmacol (1998) 0.79
Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure. Psychopharmacology (Berl) (1993) 0.79